Details

---

Manufacturer
Opella Healthcare International SAS(FRANCE)

Registraction Number
MAL15045075AZ


Content:
Each film-coated tablet contains:
-Teriflunomide: 14 mg
Indications:
-Multiple Sclerosis (MS): Used for the treatment of adult patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability2.
Instructions:
Dosage: The recommended dose is 14 mg taken orally once daily.
Administration: Swallow the tablet whole with water. It can be taken with or without food. Follow your doctor's instructions regarding the timing and duration of the medication.